Researchers discover how rheumatoid arthritis causes bone loss

August 21, 2008

Study results hold implications of autoimmune disease and osteoporosis

Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the Journal of Biological Chemistry. The findings are already guiding attempts to design new drugs to reverse RA-related bone loss and may also address more common forms of osteoporosis with a few adjustments.

Two million Americans suffer from rheumatoid arthritis (RA), which causes swelling, pain and deformity in joints and also lead to the thinning of bone. In autoimmune diseases like RA, the body's disease-fighting immune cells mistakenly identify parts of a person's body as foreign invaders, akin to bacteria, and produce chemicals to destroy them. Among the immune chemicals known to play a central in autoimmune disease is tumor necrosis factor alpha (TNF alpha), which ramps up the production of immune cells and chemicals as part of the body's response to disease. When overproduced in RA patients, TNF alpha signals for the destruction of cartilage and bone.

Beyond its control over immune cells, TNF alpha also influences bone mass. Human bone is continually regenerated to maintain strength. Under the control of signaling molecules which include TNF alpha, two cell types, balanced against each other, make bone recycling possible. Osteoclasts break down aging bone to make way for new bone, while osteoblasts build new bone at the sites where osteoclasts have removed it. Going into the study, the field understood that TNF alpha decreases the number of bone-building osteoblasts, but not how. The current study provides the first direct proof that the TNF alpha affects osteoblasts through an enzyme called Smad Ubiquitin Regulatory Factor 1 (Smurf1), which in turn shuts down two proteins that would otherwise drive bone-building.

While traditional RA drugs like NSAIDs and steroids treat symptoms, a newer class of best-selling drugs (e.g. Humira, Remicade and Enbrel) reverses the disease process by shutting down TNF alpha activity. While the new drugs are effective for many patients, others experience infections and even lymphoma in a few cases. The new drugs are based on bioengineered versions of proteins made by human immune cells called antibodies, and are very expensive to make. Thus, the field has been searching for smaller, simpler chemicals that would be effective, but with lower costs and fewer side effects.

"The significance of our study is that it identifies SMURF1 as the signaling partner through which TNF does damage in RA-related bone loss," said Lianping Xing, Ph.D., assistant professor of Pathology and Laboratory Medicine at the University of Rochester Medical Center. "That has enabled researchers to begin designing small molecule drugs to shut down the action of Smurf 1 and its relatives. Furthermore, since mice engineered to have less Smurf1 expression develop thicker bones, future drugs that shut down Smurf1 may be also useful against more common forms of osteoporosis simply by changing the dose. Of course, this is early-stage work with many obstacles ahead, but it is exciting nonetheless."

Study Details

In the late 1990s, Gerald H. Thomsen, Ph.D., at Stony Brook University in New York discovered that Smurf1 helps to attach a protein tag called ubiquitin to aging proteins in need of disposal. The tag then attracts the attention of cellular machines called proteosomes that degrade proteins.

Xing's team generated two lines of mice - one with high TNF alpha levels and with Smurf1 present, and a second group with high TNF alpha production but no Smurf1. Bone volume and strength of both groups of mice were then examined using a combination of imaging technologies and were compared. Experiments showed that increased TNF alpha levels dramatically decreased the levels of two key factors, Smad1 and Runx2. Both Smad1 and Runx2 signaled to increase the number of bone-building osteoblasts, but only if Smurf1 was present to pass on the signal from TNF alpha.

Genetically engineered mice with the Smurf1 gene removed no longer responded to TNF alpha because Smurf1 was not present to label Smad1 and Runx2 with the ubiquitin destruction tag. As expected, mice with increased TNF alpha had lesser bone mass than their counterparts, a result partially reversed in mice where Smurf1 had been removed.

Bolstering the importance of the current paper is the fact that TNF alpha promotes the destruction of some types of cancer cells. While toxic when administered systemically, it has found a niche in preventing the spread of skin cancer, where it can be injected directly into a tumor. Other drugs then became available that shut down the TNF signal by directly inhibiting the protein-eating proteosomes that receive the signal. There is an existing anti-myeloma drug on the market, bortezomib, which shuts down the proteosomes that Smurf1 partners with to destroy Smad 1 and Runx2.

Thus, Xing's team will be looking at the effect of bortezomib over the next year to see if shutting down proteosomes in bone cells does indeed increase bone mass in mice engineered to have high levels of TNF alpha. Bortezomib, is a general proteosome inhibitor, however, and does not specifically target Smurf 1, and future efforts will seek to identify Smurf1-specific drug candidates. In the meantime, the team is also seeking other groups of ligases that, like Smurf1, contribute to bone loss because experiments revealed that Smurf1 is not responsible for 100 percent of the bone loss under inflammatory conditions.

Along with Xing, the study was led by Ruolin Guo, Motozo Yamashita, Qian Zhang, Quan Zhou, Di Chen, David G. Reynolds, Hani Awad, Laura Yanoso, Lan Zhao, Edward Schwarz, Ying Zhang and Brendan Boyce within the Department of Pathology at University of Rochester. The article published today in hard copy was first published online on June 19, 2008.

"Our over-all hypothesis is that in inflammatory diseases like RA, the function of a group of enzymes like Smurf1 gets turned on to cause proteasome degradation of key regulator proteins leading to bone loss," Xing said. "The real, future solution will involve a treatment that specifically addresses each of these."

University of Rochester Medical Center

---

---

	A Resilient Life: Learning to thrive, not just survive with rheumatoid arthritis by OTR, Kat Elton (Author) Too often, people faced with a disease such as rheumatoid arthritis hear words like, "disabling," "progressive," or "tragic." "Tragic" may be what people are saying but the real tragedy is that these often repeated words do nothing but harm to those who hear them. They completely ignore a very real truth: physical issues can absolutely lead to positive transformation, action, challenge, inner strength, deep courage, and compassion. This unique book is written by someone who knows her subject well. Kat Elton, an occupational therapist and woman who's had rheumatoid arthritis since age two, knows that people with RA don't need false hope or to be told what to do. What they do need is to be led toward believing in themselves and improving their reality no matter what it is. Part practical...
	The First Year: Rheumatoid Arthritis: An Essential Guide for the Newly Diagnosed by M.E.A. McNeil (Author), Kenneth Sack MD MD (Foreword) Rheumatoid arthritis (RA), a disease characterized by inflammation of the joints, is one of the most disabling forms of arthritis and affects over two million people in the United States. Without proper treatment it can lead to long-term joint damage, chronic pain, loss of function, and disability. From the first moment of her diagnosis, author M.E.A. McNeil took charge and educated herself on every aspect of her condition. Now, as a "patient-expert," she guides those newly diagnosed step-by-step through their first year with RA. McNeil provides crucial information about the nature of the disease, treatment options, diet, exercise, social concerns, emotional issues, networking with others, and much more. The First Year—Rheumatoid Arthritis is an essential resource for everyone who wants...
	The Amazing Rheumatoid Arthritis Diet by Modern Digital Publishing Rheumatoid arthritis pain is devastating, debilitating, and it can rob you of your ability to enjoy life. But, you may not have to suffer the way you do now... in fact, a few simple yet powerful changes in what you eat could make the difference between daily crippling pain and living a normal, relatively pain-free life. Think it can't be true? No one would blame you for being skeptical - but author Michael Massie is living proof that following a special diet for rheumatoid arthritis works. Michael spent six long years suffering with arthritis pain and being so tired all the time that he couldn't enjoy life (a common complaint among rheumatoid arthritis sufferers). Then, he discovered how improving the way you eat can have a drastic effect on how you feel!
	The New Arthritis Breakthrough: The Only Medical Therapy Clinically Proven to Produce Long-term Improvement and Remission of RA, Lupus, Juvenile RS, ... & Other Inflammatory Forms of Arthritis by Henry Scammell (Author) ...can be miraculous for rheumatoid arthritis sufferers.-- Health & Healing, Tomorrow's Medicine Today
	Living with Rheumatoid Arthritis (Johns Hopkins Press Health Book) by Tammi L. Shlotzhauer (Author), James L. McGuire (Author), Carol M. Ziminski (Foreword) A trusted guide and an invaluable resource, Living with Rheumatoid Arthritis offers practical advice for the millions of people coping with this painful disease. Now thoroughly revised and expanded, in a second edition, this book brings readers up to date with the latest methods of diagnosis and treatment.Building on their accessible explanation of the disease and its causes, the authors describe the essential components of care: medication, joint protection, physical activity, and good nutrition. They provide a wealth of new information on medications, including biologic response–modifiers, alternative and complementary approaches, and treatments for osteoporosis (which often accompanies rheumatoid arthritis), and they describe safe and effective ways to cope with pain, stiffness, and...
	Conquering Arthritis: What Doctors Don't Tell You Because They Don't Know by Barbara D Allan (Author) This book is newly revised and updated with important updates that make healing from arthritis even easier and quicker. It has been used with great success by many people with rheumatoid arthritis, osteoarthritis, and other forms of arthritis, to heal themselves. It provides practical, detailed information that is critical for the successful healing of arthritis, but that has never before been collected in one place. The information is organized into a well-researched, easy-to-follow plan for getting well again and includes case histories of people with dramatic and lasting recoveries. It focuses not just on coping with the symptoms of arthritis, but on correcting its underlying causes using proven alternative medicine and pain management techniques. Anyone who is serious about...
	Rheumatoid Arthritis: The Infection Connection {Targeting and Treating the Cause of Chronic Illness} by Dr Katherine M Poehlmann PhD (Author), Dr Harold Clark PhD (Introduction), Dr Joseph Mercola DO (Introduction) Foreword by Dr. Harold Clark, author of "Why Arthritis?" and lab manager for Dr. Thomas McPherson Brown, author of "The Road Back." Appendices by Dr. Joseph Mercola, D.O. (www.mercola.com) and Dr. Garth Nicolson (www.immed.org) IN THIS BOOK YOU WILL DISCOVER: -- Actions of microorganisms that cause RA-mycoplasmas, mycobacteria, molds, spirochetes (e.g., Lyme), viruses, bacteria and their cell wall deficient L-forms; -- Their role in other chronic illnesses with arthritis-like symptoms such as Fibromyalgia, Lupus, Multiple Sclerosis, and Chronic Fatigue Syndrome; -- Online authoritative medical information and support organizations; -- The best Internet sites to research health, drugs, treatments, and disease; -- What diagnostic tests are available and where to get...
	Death by Rheumatoid Arthritis by Echelon Press More than a million Americans suffer from rheumatoid arthritis. The numbers of deaths from this disease continues to climb each year. Late diagnosis and treatment for arthritis related, cervical spine deterioration, is one reason for some of these deaths. Celia Veno, a Bucks County retired woman and mother was one of those fatalities. Celia Veno, a woman in her 70’s, began, experiencing mysterious migraine-like headaches and atrophy. After her general doctor and neurologist failed to determine the cause of these symptoms, a new rheumatologist was called upon. He immediately diagnosed from a previous cervical spine x-ray, that she had advanced spinal cord syndrome. Unfortunately, the findings came critically late. She died two months later. Eighty-six percent of...
	Rheumatoid Arthritis: 3rd edition by Jasmine Jenkins (Author) How to manage your Rheumatoid Arthritis by becoming an expert patient. This book will enable you to: - Understand more about Rheumatoid Arthritis and the medication involved - Reduce the pain that you experience - Use joint protection techniques - Appreciate the importance of exercise and good posture - Relax and manage your stress - Adapt to the changes in your working and leisure life - Achieve a positive outlook. There's also an A-Z of well being and a list of useful resources.
	How to Eat Away Arthritis: Gain Relief from the Pain and Discomfort of Arthritis Through Nature's Remedies by Laurie M. Aesoph (Author) This revised and expanded edition of the perennially popular self-help book details how arthritis sufferers can improve their conditions with the foods they eat. Using the simple dietary procedures described in this book, readers can reverse some cases of osteoarthritis or rheumatoid arthritis without expensive drugs or equipment.